Skip to main content
. 2022 Aug 18;12:964779. doi: 10.3389/fonc.2022.964779

Figure 5.

Figure 5

Pooled analysis of PFS in patients with HCC treated with immune checkpoint inhibitors combined with antiangiogenic drugs.